ArticleCancer immunology research2024

Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments.

Jenna H Rannikko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.